MANAGED ACCOUNT ADVISORS LLC - AUSPEX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of AUSPEX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$6,000
-33.3%
63
-63.4%
0.00%
Q4 2014$9,000
+28.6%
172
-32.8%
0.00%
Q3 2014$7,000
+40.0%
256
+14.8%
0.00%
Q2 2014$5,000
-28.6%
2230.0%0.00%
Q1 2014$7,0002230.00%
Other shareholders
AUSPEX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 152,002$3,902,0003.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,512,160$64,487,0002.35%
Iguana Healthcare Management, LLC 90,000$2,310,0001.23%
WALL STREET ASSOCIATES 435,000$11,166,0001.15%
KNOTT DAVID M 128,500$3,298,595,0000.63%
Cormorant Asset Management, LP 100,000$2,567,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 165,074$4,237,0000.52%
Granite Point Capital Management, L.P. 40,000$1,027,0000.51%
KINGDON CAPITAL MANAGEMENT, L.L.C. 423,879$10,872,0000.49%
Perceptive Advisors 100,000$2,567,0000.28%
View complete list of AUSPEX PHARMACEUTICALS INC shareholders